XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning of period (in shares) at Mar. 31, 2022     164,372,545          
Beginning of period at Mar. 31, 2022 $ 1,046,721   $ 1,646 $ (1,635,454) $ 656,222 $ 2,015,071 $ 8,585 $ 651
Beginning of period (in shares) at Mar. 31, 2022       (31,788,197)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     590,027          
Issuance of common stock 18,003   $ 4   17,999      
Stock options exercised (in shares)     300,276          
Stock options exercised 10,705   $ 3   10,702      
Repurchase of common stock (in shares)   (1,000,000)   (1,118,816) [1]        
Repurchase of common stock (98,236) [1] $ (86,400)   $ (98,236) [1]        
Net income 339,563         340,213   (650)
Other comprehensive (loss) income, net of tax 13,494           13,494  
Dividends declared (172,669)         (172,669)    
Stock-based compensation expense 50,992       50,992      
Contribution to non-controlling interest 0       (2,893)     2,893
De-consolidation of non-controlling interest (2,894)             (2,894)
End of period (in shares) at Dec. 31, 2022     165,262,848          
End of period at Dec. 31, 2022 1,205,679   $ 1,653 $ (1,733,690) 733,022 2,182,615 22,079 0
End of period (in shares) at Dec. 31, 2022       (32,907,013)        
Beginning of period (in shares) at Sep. 30, 2022     165,110,617          
Beginning of period at Sep. 30, 2022 1,218,535   $ 1,651 $ (1,722,881) 706,620 2,208,952 22,141 2,052
Beginning of period (in shares) at Sep. 30, 2022       (32,795,658)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     86,802          
Issuance of common stock 5,951   $ 0   5,951      
Stock options exercised (in shares)     65,429          
Stock options exercised 2,713   $ 2   2,711      
Repurchase of common stock (in shares)       (111,355)        
Repurchase of common stock (10,809)     $ (10,809)        
Net income 30,689         30,997   (308)
Other comprehensive (loss) income, net of tax (62)           (62)  
Dividends declared (57,334)         (57,334)    
Stock-based compensation expense 18,890       18,890      
Contribution to non-controlling interest 0       (1,150)     1,150
De-consolidation of non-controlling interest (2,894)             (2,894)
End of period (in shares) at Dec. 31, 2022     165,262,848          
End of period at Dec. 31, 2022 $ 1,205,679   $ 1,653 $ (1,733,690) 733,022 2,182,615 22,079 $ 0
End of period (in shares) at Dec. 31, 2022       (32,907,013)        
Beginning of period (in shares) at Mar. 31, 2023 131,637,588   165,872,332          
Beginning of period at Mar. 31, 2023 $ 992,002   $ 1,659 $ (1,859,905) 769,460 2,051,455 29,333  
Beginning of period (in shares) at Mar. 31, 2023 (34,234,744)     (34,234,744)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     610,945          
Issuance of common stock $ 20,899   $ 6   20,893      
Stock options exercised (in shares)     315,796          
Stock options exercised 14,409   $ 3   14,406      
Repurchase of common stock (in shares)   (2,500,000)   (2,625,279) [2]        
Repurchase of common stock (289,829) [2] $ (272,800)   $ (289,829) [2]        
Net income 477,750         477,750    
Other comprehensive (loss) income, net of tax (3,830)           (3,830)  
Dividends declared (186,435)         (186,435)    
Stock-based compensation expense $ 61,277       61,277      
End of period (in shares) at Dec. 31, 2023 129,939,050   166,799,073          
End of period at Dec. 31, 2023 $ 1,086,243   $ 1,668 $ (2,149,734) 866,036 2,342,770 25,503  
End of period (in shares) at Dec. 31, 2023 (36,860,023)     (36,860,023)        
Beginning of period (in shares) at Sep. 30, 2023     166,669,125          
Beginning of period at Sep. 30, 2023 $ 1,072,130   $ 1,667 $ (2,054,418) 834,042 2,258,947 31,892  
Beginning of period (in shares) at Sep. 30, 2023       (36,095,259)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     106,446          
Issuance of common stock 6,952   $ 1   6,951      
Stock options exercised (in shares)     23,502          
Stock options exercised 1,276   $ 0   1,276      
Repurchase of common stock (in shares)       (764,764)        
Repurchase of common stock (95,316)     $ (95,316)        
Net income 145,644         145,644    
Other comprehensive (loss) income, net of tax (6,389)           (6,389)  
Dividends declared (61,821)         (61,821)    
Stock-based compensation expense $ 23,767       23,767      
End of period (in shares) at Dec. 31, 2023 129,939,050   166,799,073          
End of period at Dec. 31, 2023 $ 1,086,243   $ 1,668 $ (2,149,734) $ 866,036 $ 2,342,770 $ 25,503  
End of period (in shares) at Dec. 31, 2023 (36,860,023)     (36,860,023)        
[1] During the nine months ended December 31, 2022, the Company purchased 1.0 million shares of the Company’s Class A Common Stock in a series of open market transactions for $86.4 million. Additionally, the Company repurchased shares for $11.8 million during the nine months ended December 31, 2022 to cover the minimum statutory withholding taxes on restricted stock units that vested on various dates during the period.
[2] During the nine months ended December 31, 2023, the Company purchased 2.5 million shares of the Company’s Class A Common Stock in a series of open market transactions for $272.8 million. Additionally, the Company repurchased shares for $14.9 million during the nine months ended December 31, 2023 to cover the minimum statutory withholding taxes on restricted stock units that vested on various dates during the period.